Senores Pharmaceuticals informs about updates

22 Apr 2025 Evaluate
With reference to the intimations dated March 11, 2025 and March 12, 2025, regarding acquisition of 8454 equity shares from certain shareholders (Public Category) of Havix Group Inc. D/B/A Aavis Pharmaceuticals, Senores Pharmaceuticals has informed that out of the said 8454 equity shares, the acquisition of 7914 equity shares have been completed and acquisition of 540 equity shares is under process due to requirement of certain approvals from Reserve Bank of India (RBI). In view of the above, the time-period for completion of acquisition of the remaining 540 equity shares has been further extended by 60 (sixty) days.

The above information is a part of company’s filings submitted to BSE.

Senores Pharmaceutic Share Price

777.40 -6.85 (-0.87%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×